Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency (Proceedings of the National Academy of Sciences of the United States of America, 2020)

(untitled) - Patutina, OA; Gaponova Miroshnichenko, SK; Sen'kova, AV; Savin, IA; Gladkikh, DV; Burakova, EA; Fokina, AA; Maslov, MA; Shmendel', EV; Wood, MJA; Vlassov, VV; Altman, S; et al.